PDCD1 and neoplasm: Another immunological checkpoint that facilitates tumor cell evasion involves the interaction between Programmed Death-1 (PD-1; CD279) and Programmed Death Receptor Ligand-1 (PD-L1; also known as CD274 or B7-H1).